← Back to Search

Physician Training for Early Detection of Skin Cancer

N/A

Waitlist Available

Led By Susan A Flocke, Ph.D.

Research Sponsored by OHSU Knight Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

These individuals are all aged 18 years or older

All practice members speak English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

Study Summary

This trial looks at how to help primary care physicians diagnose and treat skin cancer like melanoma earlier, increasing the chances of a successful outcome.

Who is the study for?

This trial is for English-speaking primary care physicians at two OHSU clinics, aged 18 or older. It's designed to see if training can help them better detect and manage skin cancer. One group will receive the educational intervention on melanoma detection while another won't, serving as a comparison.Check my eligibility

What is being tested?

The study is testing an educational program aimed at improving primary care doctors' abilities to spot, diagnose, treat, or refer cases of early-stage melanoma and other skin cancers through enhanced training and education.See study design

What are the potential side effects?

Since this trial involves an educational intervention rather than a medical treatment, there are no direct physical side effects expected from participating in the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

Everyone in my medical team speaks English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinician knowledge in screening for skin cancer

Reach of the educational intervention

Use of risk assessment tool

Secondary outcome measures

Identification of suspicious lesions

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Other, PragmaticExperimental Treatment1 Intervention

PCP participants complete group training and online training sessions. All training participants will also be offered series of short booster teaching points delivered virtually. Participants who complete the training also take part in pre-post knowledge assessments. PCP participants may also participate in a qualitative interview.

Group II: Comparison groupActive Control1 Intervention

PCPs at the two clinics who are in pods that are not assigned to receive the intervention will serve as study comparators. Comparison group has no exposure to the group or online training sessions.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor

230 Previous Clinical Trials

2,090,646 Total Patients Enrolled

Oregon Health and Science UniversityOTHER

974 Previous Clinical Trials

7,385,832 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,672 Previous Clinical Trials

40,926,361 Total Patients Enrolled

Media Library

Other, Pragmatic Clinical Trial Eligibility Overview. Trial Name: NCT05675709 — N/A

Skin Cancer Research Study Groups: Comparison group, Other, Pragmatic

Skin Cancer Clinical Trial 2023: Other, Pragmatic Highlights & Side Effects. Trial Name: NCT05675709 — N/A

Other, Pragmatic 2023 Treatment Timeline for Medical Study. Trial Name: NCT05675709 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots for participants in this research?

"The clinicaltrial.gov database reveals that this particular trial is no longer recruiting patients. Initially posted on the first of January 2023, and last modified on December 29th 2022, it has since been replaced by 179 other trials actively seeking candidates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Skin Cancer Early Detection and Treatment in Primary Care

Susan A. Flocke, Ph.D. 2023. "Enhancing Skin Cancer Early Detection and Treatment in Primary Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05675709.